Survival improvements with adjuvant therapy in patients with glioblastoma.

Abstract

BACKGROUND Evaluate survival of patients diagnosed with glioblastoma multiforme (GBM) managed with adjuvant intensity modulated radiation therapy and temozolomide since the introduction of the European Organisation for Research and Treatment of Cancer and National Cancer Institute of Canada Clinical Trials Group (EORTC-NCIC) protocol. METHODS All patients… (More)
DOI: 10.1111/ans.14153

Topics

Cite this paper

@article{Jayamanne2017SurvivalIW, title={Survival improvements with adjuvant therapy in patients with glioblastoma.}, author={Dasantha Jayamanne and Helen Ruth Wheeler and Raymond John Cook and Charles M. Teo and David H Brazier and Geoff Paul Schembri and Marina Kastelan and Linxin Guo and Michael F Back}, journal={ANZ journal of surgery}, year={2017} }